524636 — Oxygenta Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Oxygenta Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2022 March 31st	C2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	—	—	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	1.56	1.06	1.01	1.22	21.5
Net Total Accounts Receivable
Net Total Receivables	15.8	102	73.6	51	100
Total Inventory
Total Other Current Assets
Total Current Assets	95.6	250	241	309	514
Net Property, Plant And Equipment	203	279	294	371	476
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	312	543	632	828	1,197
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	80.7	329	337	858	861
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	658	1,005	833	1,084	1,624
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	-346	-462	-201	-256	-427
Total Liabilities & Shareholders' Equity	312	543	632	828	1,197
Total Common Shares Outstanding